# Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy

> **NCT07337876** · PHASE2 · RECRUITING · sponsor: **University Hospital Tuebingen** · enrollment: 100 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **RADIATION:** Dose escalated radiotherapy using a 1.5 T MR-Linac

## Key facts

- **NCT ID:** NCT07337876
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-07
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07337876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07337876, "Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07337876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*